Pennan Barry, MD

Education
Fellowship, 2009 - Infectious Diseases, University of California, San Francisco
Fellowship, 2007 - Epidemic Intelligence Service, Centers for Disease Control and Prevention
Residency, 2005 - Internal Medicine, Johns Hopkins Hospital
MD, 2002 - School of Medicine, Johns Hopkins University
MPH, 2001 - School of Hygiene and Public Health, Johns Hopkins University
Websites
Publications

  1. Bertumen JB, Pascopella L, Han E, Glenn-Finer R, Wong RJ, Chitnis A, Jaganath D, Jewell MP, Gounder P, McElroy S, Stockman L, Barry P. Expected vs Reported Chronic Hepatitis B Infection Cases in Persons with Active Tuberculosis - California, 2016-2020. Journal of public health management and practice : JPHMP 2024. PMID: 38985652


  2. Bertumen JB, Pascopella L, Han E, Glenn-Finer R, Wong RJ, Chitnis A, Jaganath D, Jewell M, Gounder P, McElroy S, Stockman L, Barry P. Epidemiology and Treatment Outcomes of Tuberculosis With Chronic Hepatitis B Infection-California, 2016-2020. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2024. PMID: 38531668


  3. Campbell JR, Brode SK, Barry P, Bastos ML, Bonnet M, Guglielmetti L, Kempker R, Klimuk D, Laborín RL, Milanov V, Singla R, Skrahina A, Trajman A, van der Werf TS, Viiklepp P, Menzies D. Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis. Thorax 2023. PMID: 38135489


  4. Han E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, Moore M, Kadakia A, Henry H, Cilnis M, Buhain S, Chitnis A, Chakrabarty M, Ky A, Nguyen Q, Low J, Jain S, Higashi J, Barry PM, Flood J. Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020. Emerging infectious diseases 2024. PMID: 38147063


  5. Linde LR, Readhead A, Barry PM, Balmes JR, Lewnard JA. Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California. American journal of respiratory and critical care medicine 2023. PMID: 36103611


  6. Katrak S, Han E, Readhead A, Fung M, Keh C, Flood J, Barry P. Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2022. PMID: 36695700


  7. Le V, Pascopella L, Westenhouse J, Barry P. A cross-sectional study of patients with extrapulmonary tuberculosis and normal chest radiographs - what characteristics were associated with sputum culture positivity? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022. PMID: 35514293


  8. Bakhsh Y, Readhead A, Flood J, Barry P. Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California. Journal of immigrant and minority health 2022. PMID: 36445646


  9. Mase A, Lowenthal P, True L, Henry L, Barry P, Flood J. Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis. Open forum infectious diseases 2022. PMID: 36601556


  11. Nabity SA, Han E, Lowenthal P, Henry H, Okoye N, Chakrabarty M, Chitnis AS, Kadakia A, Villarino E, Low J, Higashi J, Barry PM, Jain S, Flood J. Sociodemographic Characteristics, Comorbidities, and Mortality Among Persons Diagnosed With Tuberculosis and COVID-19 in Close Succession in California, 2020. Volume 4 of Issue 12. JAMA network open 2021. PMID: 34860244


  12. Mirzazadeh A, Kahn JG, Haddad MB, Hill AN, Marks SM, Readhead A, Barry PM, Flood J, Mermin JH, Shete PB. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity. Volume 16 of Issue 4. PloS one 2021. PMID: 33793612


  13. Katrak S, Lowenthal P, Shen R, True L, Henry L, Barry P. Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California. Volume 23. Journal of clinical tuberculosis and other mycobacterial diseases 2021. PMID: 33598568


  14. Mase S, Chorba T, Parks S, Belanger A, Dworkin F, Seaworth B, Warkentin J, Barry P, Shah N. Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States. Volume 71 of Issue 4. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 31556947


  15. Vaisman A, Barry P, Flood J. Assessing Complexity Among Patients With Tuberculosis in California, 1993-2016. Volume 7 of Issue 8. Open forum infectious diseases 2020. PMID: 32793763


  16. Parriott A, Kahn JG, Ashki H, Readhead A, Barry PM, Goodell AJ, Flood J, Shete PB. Modeling the Impact of Recommendations for Primary Care-Based Screening for Latent Tuberculosis Infection in California. Public health reports (Washington, D.C. : 1974) 2020. PMID: 32735191


  17. Menzies NA, Parriott A, Shrestha S, Dowdy DW, Cohen T, Salomon JA, Marks SM, Hill AN, Winston CA, Asay G, Barry P, Readhead A, Flood J, Kahn JG, Shete PB. Comparative Modelling of Tuberculosis Epidemiology and Policy Outcomes in California. American journal of respiratory and critical care medicine 2019. PMID: 31626560


  18. Katrak S, Barry P. Preventing Tuberculosis Disease: Making a Case for Enhanced Tuberculosis Screening in People Immigrating to Low-incidence Countries. Volume 69 of Issue 12. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. PMID: 30855071


  19. Blount RJ, Pascopella L, Barry P, Zabner J, Stapleton EM, Flood J, Balmes J, Nahid P, Catanzaro DG. Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California. The Science of the total environment 2019. PMID: 32000313


  20. Duque-Silva A, Hampole V, Cheng YN, Flood J, Barry PM. Outcomes of Pediatric Central Nervous System Tuberculosis in California, 1993-2011. Volume 8 of Issue 5. Journal of the Pediatric Infectious Diseases Society 2019. PMID: 30189047


  21. Shrestha S, Cherng S, Hill AN, Reynolds S, Flood J, Barry PM, Readhead A, Oxtoby M, Lauzardo M, Privett T, Marks SM, Dowdy DW. Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis. Volume 188 of Issue 9. American journal of epidemiology 2019. PMID: 31251797


  22. Lowenthal P, Lin SG, Desmond E, Shah N, Flood J, Barry PM. Evaluation of the Impact of a Sequencing Assay for Detection of Drug Resistance on the Clinical Management of Tuberculosis. Volume 69 of Issue 4. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2019. PMID: 30383209


  23. Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG. Outlook for tuberculosis elimination in California: An individual-based stochastic model. PloS one 2019. PMID: 30964878


  24. Osman M, Harausz EP, Garcia-Prats AJ, Schaaf HS, Moore BK, Hicks RM, Achar J, Amanullah F, Barry P, Becerra M, Chiotan DI, Drobac PC, Flood J, Furin J, Gegia M, Isaakidis P, Mariandyshev A, Ozere I, Shah NS, Skrahina A, Yablokova E, Seddon JA, Hesseling AC, Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR TB. Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis. Volume 25 of Issue 3. Emerging infectious diseases 2019. PMID: 30789141


  25. Higashi J, Barry P. Not So Fast: Slowing Tuberculosis Decline in California. Volume 109 of Issue 2. American journal of public health 2019. PMID: 30649944


  26. Belanger A, Morris SB, Brostrom R, Yost D, Goswami N, Oxtoby M, Moore M, Westenhouse J, Barry PM, Shah NS. Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States. Volume 15. Journal of clinical tuberculosis and other mycobacterial diseases 2019. PMID: 31720417


  27. Okada RC, Barry PM, Skarbinski J, Chitnis AS. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Volume 39 of Issue 11. Infection control and hospital epidemiology 2018. PMID: 30231948


  28. Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Volume 392 of Issue 10150. Lancet (London, England) 2018. PMID: 30215381


  29. Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC, Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in MDR-TB. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. Volume 15 of Issue 7. PLoS medicine 2018. PMID: 29995958


  30. Barry PM, True L. Using evidence to improve adherence and outcomes: personalized packages of patient support. Volume 22 of Issue 7. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2018. PMID: 29914593


  31. Beavers SF, Pascopella L, Davidow AL, Mangan JM, Hirsch-Moverman YR, Golub JE, Blumberg HM, Webb RM, Royce RA, Buskin SE, Leonard MK, Weinfurter PC, Belknap RW, Hughes SE, Warkentin JV, Welbel SF, Miller TL, Kundipati SR, Lauzardo M, Barry PM, Katz DJ, Garrett DO, Graviss EA, Flood JM, Tuberculosis Epidemiologic Studies Consortium. Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities. Volume 15 of Issue 6. Annals of the American Thoracic Society 2018. PMID: 29490150


  32. Kay AW, Islam SM, Wendorf K, Westenhouse J, Barry PM. Interferon-γ Release Assay Performance for Tuberculosis in Childhood. Volume 141 of Issue 6. Pediatrics 2018. PMID: 29728429


  33. Barry PM, Lowenthal P, True L, Henry L, Schack G, Wendorf K, Flood J, Shah N. Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria. Volume 196 of Issue 11. American journal of respiratory and critical care medicine 2017. PMID: 28665681


  34. Flood J, Barry PM. Mainstreaming Latent Tuberculosis Infection Testing and Treatment in the United States: Who and How. Volume 177 of Issue 12. JAMA internal medicine 2017. PMID: 29049821


  35. Smith SE, Pratt R, Trieu L, Barry PM, Thai DT, Ahuja SD, Shah S. Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014. Volume 65 of Issue 9. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. PMID: 28633501


  36. Blount RJ, Pascopella L, Catanzaro DG, Barry PM, English PB, Segal MR, Flood J, Meltzer D, Jones B, Balmes J, Nahid P. Traffic-Related Air Pollution and All-Cause Mortality during Tuberculosis Treatment in California. Volume 125 of Issue 9. Environmental health perspectives 2017. PMID: 28963088


  37. Oh P, Pascopella L, Barry PM, Flood JM. A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015. Volume 10 of Issue 1. BMC research notes 2017. PMID: 28854957


  38. Kay A, Barry PM, Annambhotla P, Greene C, Cilnis M, Chin-Hong P, Arger N, McNitt L, Neidlinger N, Shah N, Basavaraju SV, Kuehnert M, Shaw T. Solid Organ Transplant-Transmitted Tuberculosis Linked to a Community Outbreak - California, 2015. MMWR. Morbidity and mortality weekly report 2017. PMID: 28771459


  39. Lowenthal P, Barry PM, Flood J. Re: "Prebiologic Therapy Tuberculosis Screening Experience in a Pediatric Rheumatology Center: TST and IGRA Are Both Necessary". Volume 36 of Issue 4. The Pediatric infectious disease journal 2017. PMID: 28288086


  40. Peralta G, Barry P, Pascopella L. Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010-2013. Volume 3 of Issue 4. Open forum infectious diseases 2016. PMID: 27957506


  41. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Volume 63 of Issue 7. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016. PMID: 27621353


  42. Shah NS, Grace Lin SY, Barry PM, Cheng YN, Schecter G, Desmond E. Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003-2013. Volume 3 of Issue 3. Open forum infectious diseases 2016. PMID: 27704008


  43. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Volume 63 of Issue 7. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016. PMID: 27516382


  44. Barry PM, Kay AW, Flood JM, Watt J. Getting to Zero: Tuberculosis Elimination in California. Volume 3. Current epidemiology reports 2016. PMID: 27218013


  46. Duque-Silva A, Robsky K, Flood J, Barry PM. Risk Factors for Central Nervous System Tuberculosis. Volume 136 of Issue 5. Pediatrics 2015. PMID: 26438712


  47. Chitnis AS, Davis JL, Schecter GF, Barry PM, Flood JM. Review of nucleic acid amplification tests and clinical prediction rules for diagnosis of tuberculosis in acute care facilities. Volume 36 of Issue 10. Infection control and hospital epidemiology 2015. PMID: 26166303


  48. Chitnis AS, Robsky K, Schecter GF, Westenhouse J, Barry PM. Trends in Tuberculosis Cases Among Nursing Home Residents, California, 2000 to 2009. Volume 63 of Issue 6. Journal of the American Geriatrics Society 2015. PMID: 26096384


  49. Demlow SE, Oh P, Barry PM. Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010-2012. Volume 15. BMC public health 2015. PMID: 25884596


  50. Coscolla M, Barry PM, Oeltmann JE, Koshinsky H, Shaw T, Cilnis M, Posey J, Rose J, Weber T, Fofanov VY, Gagneux S, Kato-Maeda M, Metcalfe JZ. Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread. Volume 212 of Issue 2. The Journal of infectious diseases 2015. PMID: 25601940


  51. Kelly JD, Grace Lin SY, Barry PM, Keh C, Higashi J, Metcalfe JZ. Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection. Volume 190 of Issue 11. American journal of respiratory and critical care medicine 2014. PMID: 25436783


  52. Ehman M, Flood J, Barry PM. Tuberculosis treatment managed by providers outside the Public Health Department: lessons for the Affordable Care Act. Volume 9 of Issue 10. PloS one 2014. PMID: 25340876


  53. Pascopella L, Barry PM, Flood J, DeRiemer K. Death with tuberculosis in california, 1994-2008. Volume 1 of Issue 3. Open forum infectious diseases 2014. PMID: 25734158


  54. Chitnis AS, Schecter GF, Cilnis M, Robsky K, Flood JM, Barry PM. Epidemiology of tuberculosis cases with end-stage renal disease, California, 2010. Volume 39 of Issue 4. American journal of nephrology 2014. PMID: 24751696


  55. Prach LM, Pascopella L, Barry PM, Flood J, Porco TC, Hopewell PC, Metcalfe JZ. Rifampin monoresistant tuberculosis and HIV comorbidity in California, 1993-2008: a retrospective cohort study. Volume 27 of Issue 16. AIDS (London, England) 2013. PMID: 23842135


  56. Bernstein KT, Marcus JL, Barry PM, Pandori MW, Buono S, Hess D, Philip SS. Characteristics of males infected with common Neisseria gonorrhoeae sequence types in the Gonococcal Isolate Surveillance Project, San Francisco, California, 2009. Volume 178 of Issue 8. American journal of epidemiology 2013. PMID: 24049157


  57. Ehman M, Shaw T, Cass A, Lawton E, Westenhouse J, Young J, Royce S, Barry P. Developing and using performance measures based on surveillance data for program improvement in tuberculosis control. Volume 19 of Issue 5. Journal of public health management and practice : JPHMP 2013. PMID: 23263627


  58. Hess D, Wu A, Golparian D, Esmaili S, Pandori W, Sena E, Klausner JD, Barry P, Unemo M, Pandori M. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Volume 56 of Issue 11. Antimicrobial agents and chemotherapy 2012. PMID: 22908152


  59. Buono S, Wu A, Hess DC, Carlson JS, Rauch L, Philip SS, Barry P, Bernstein K, Klausner JD, Pandori MW. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California. Volume 18 of Issue 5. Microbial drug resistance (Larchmont, N.Y.) 2012. PMID: 22686196


  60. Stoltey JE, Barry PM. The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. Volume 13 of Issue 10. Expert opinion on pharmacotherapy 2012. PMID: 22646654


  61. Barry PM, Gardner TJ, Funk E, Oren E, Field K, Shaw T, Langer AJ. Multistate outbreak of MDR TB identified by genotype cluster investigation. Volume 18 of Issue 1. Emerging infectious diseases 2012. PMID: 22260877


  62. Marcus JL, Kohn RP, Barry PM, Philip SS, Bernstein KT. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the female oropharynx to the male urethra. Volume 38 of Issue 5. Sexually transmitted diseases 2011. PMID: 21183864


  63. Barry PM, Kent CK, Philip SS, Klausner JD. Results of a program to test women for rectal chlamydia and gonorrhea. Volume 115 of Issue 4. Obstetrics and gynecology 2010. PMID: 20308835


  64. Bernstein KT, Stephens SC, Barry PM, Kohn R, Philip SS, Liska S, Klausner JD. Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Volume 49 of Issue 12. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009. PMID: 19911970


  65. Li L, Barry P, Yeh E, Glaser C, Schnurr D, Delwart E. Identification of a novel human gammapapillomavirus species. Volume 90 of Issue Pt 10. The Journal of general virology 2009. PMID: 19570953


  66. Pandori M, Barry PM, Wu A, Ren A, Whittington WL, Liska S, Klausner JD. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Volume 53 of Issue 9. Antimicrobial agents and chemotherapy 2009. PMID: 19546370


  67. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Volume 10 of Issue 4. Expert opinion on pharmacotherapy 2009. PMID: 19284360


  68. Barry PM, Kent CK, Scott KC, Goldenson J, Klausner JD. Is jail screening associated with a decrease in Chlamydia positivity among females seeking health services at community clinics?-San francisco, 1997-2004. Volume 36 of Issue 2 Suppl. Sexually transmitted diseases 2009. PMID: 18418298


  69. Barry PM, Kent CK, Klausner JD. Risk factors for gonorrhea among heterosexuals--San Francisco, 2006. Volume 36 of Issue 2 Suppl. Sexually transmitted diseases 2009. PMID: 18418303


  70. Barry PM, Scott KC, McCright J, Snell A, Lee M, Bascom T, Kent CK, Klausner JD. Stay in school? Results of a sexually transmitted diseases screening program in San Francisco high schools-2007. Volume 35 of Issue 6. Sexually transmitted diseases 2008. PMID: 18356770


  71. Siedner MJ, Pandori M, Leon SR, Barry PM, Espinosa BJ, Hall ER, Coates TJ, Klausner JD, NIMH Collaborative HIV/STD Prevention Trial Group. Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction. Volume 19 of Issue 1. International journal of STD & AIDS 2008. PMID: 18275657


  72. Barry PM, Kent CK, Scott KC, Snell A, Goldenson J, Klausner JD. Optimising sexually transmitted infection screening in correctional facilities: San Francisco, 2003-2005. Volume 83 of Issue 5. Sexually transmitted infections 2007. PMID: 17567685


  73. Siedner MJ, Pandori M, Castro L, Barry P, Whittington WL, Liska S, Klausner JD. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. Volume 45 of Issue 4. Journal of clinical microbiology 2007. PMID: 17267635


  74. Barry PM, Klausner JD. The impact of STIs. Volume 38 of Issue 10. MLO: medical laboratory observer 2006. PMID: 17086827


  75. Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. Volume 20 of Issue 3. AIDS (London, England) 2006. PMID: 16439878